Commercialization: Page 19

PharmaVoice Team/PharmaVoice

After Approval, Can Gene Therapies Achieve Marketing Success?

Having a well-designed plan that addresses the needs of all stakeholders — patients and their families, medical institutions, payers and manufacturers — will help drive successful outcomes. The advent of gene therapy — personalized medicine reflecting the potential to minimize or cure disease — i...
By Denise Myshko • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

The Future of Decentralized Trials

Our industry leaders had much to say about patients participating in clinical trials from home, from community sites, virtually — in essence a hybrid of the current system. What would be the impact of siteless trials on clinical development? A provocative question, and one that we posed recognizi...
By PharmaVoice Team • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Real-Time Hope for Rare Diseases

With advances in genomics sequencing combined with AI and other tools to speed up data analysis, the potential for quickly diagnosing and ultimately developing therapies that can treat patients with rare diseases in real time grows. The rare diseases space has come on leaps and bounds over the pa...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Behavioral Science's Impact on Marketing

Behavioral science enables pharma to acquire a greater understanding of its consumers and how to better message them in order to motivate them to change their behavior. Are you a promoter or a preventer? According to the book, “Why We Resist," written by Syneos Health Communications’ experts Leig...
By Robin Robinson • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Patient Influencers Are Transforming Pharma Marketing Strategies

Companies need to harness the power of social media community influencers — the new healthcare decision makers. Social media provides a huge opportunity for pharma companies to engage with patient leaders and connect to their larger community audiences. Working with advocates and influencers not ...
By Robin Robinson • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

The Changing Role of the Traditional Pharma Brand

Experts say the industry needs to reinvent its role to create value in diagnostics, prevention, and digital health solutions beyond its traditional brands. According to a Strategy& report out earlier this year, healthcare will be centered on patients who are empowered to prevent diseases rath...
By Robin Robinson • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Dr. Robot

Robots and docs — automation and clinician. In Disney’s animated hit Big Hero 6, we got a glimpse of what a future of a robot-enabled healthcare future might look like. Disney’s Baymax is an inflatable robot whose sole purpose is to take care of people in everyday life. But real-life medical robo...
By Taren Grom • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Wearing Your health: The Case for Smart Clothing

As the wearable market continues to expand, the potential for smart clothing to monitor and manage health is breaking new ground. The market for wearables is continuing to grow as more companies enter the space and as more and more consumers acquire devices. According to IDTechEx, the market for ...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Putting Healthcare IoT in the Home

The futuristic concept of remote monitoring of patients using the Internet of Things is already here and being used to improve health outcomes. Digitization has become a reality in healthcare, and it’s helping to drive more patient choice, including the ability to manage patient health from the h...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Patient Care: Treatment to Cure

Moving the industry from a focus on treatment to a focus on prevention will require data, new financial incentives, and a change in how healthcare is delivered and paid for. Today, the U.S. healthcare system is a collection of disconnected components: health plans, hospital systems, pharmaceutica...
By PharmaVoice Team • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Bringing Humanity Back to Healthcare

Technology can seem impersonal, but it can also be the driver for enabling more personal connections with patients. From the development of medicines by pharma companies to advancements in treatment protocols to using data to better apply therapeutic regimens, the healthcare industry is committed...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Can Healthcare Be Equitable?

Addressing disparities in health is key to achieving progress toward health equity, but in a complex environment how can these goals be achieved? According to the World Health Organization, equity is “the absence of avoidable or remediable differences among groups of people." From a healthcare pe...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Technology Plus Science: New Company Model?

We asked a variety of experts what would happen if Apple, Amazon, Google or another big technology company bought a pharma company? Our experts are divided on the likelihood of this happening, but if it did, they say it would be transformational. For more than a decade we have been discussing the...
By Robin Robinson • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

A Crisis of Trust: Pharma's Battle to Win Back Public Confidence

A Gallup poll ranks the pharmaceutical industry at rock bottom in terms of trust. So what can pharma do to overcome its image problem? Public trust in the pharmaceutical industry is at an all-time low. Data from Gallup’s latest Work and Education poll, carried out in the first two weeks of August...
By Kim Ribbink • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Inspiring the Next Generation

To solve the industry’s biggest challenges, healthcare companies need to attract and engage the brightest talent. Gen Tech, Gen Wii, Net Gen, Digital Natives — these are some of the descriptors used to identify the next generation of the workforce. While Millennials will account for 50% of the gl...
By Taren Grom • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

The Uptick in AI Use Will Bring Pharma Into the Future Faster

The top 10 pharma companies have all collaborated with or acquired AI technologies: Novartis, Roche, Pfizer, Merck, AstraZeneca, GSK, Sanofi, Abbvie, Bristol-Myers Squibb, and Johnson & Johnson. Reports projecting where the industry would be in terms of artificial intelligence (AI) in 2020 pr...
By Robin Robinson • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Speak Out: How Relationship Marketing Can Deliver an Unparalleled Patient Brand Experience

When it comes to patient engagement, pharma marketers must modernize their approach, making it more personalized and proactive, because the expectations of patients are changing. With companies like Amazon influencing them, patients have come to expect a user experience that is flawlessly tailore...
By Anne Marie White • Nov. 19, 2019
PharmaVoice Team/PharmaVoice

Letter from the Editor

Virtual Healthcare The intersection of health and technology is revving up. Exciting new developments to improve care across the board — from clinical trials to at-home diagnostics and treatments — seemingly come to light on a daily basis. As we discuss in this month’s cover story, healthcare is ...
By Taren Grom • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Upfront

Alnylam Launches Animated Video Series for Kids with PH1 In September, Alnylam launched PH1 of a Kind, a new animated video series for children living with primary hyperoxaluria type 1 (PH1). The four-part video series stars Isabelle, Luuk, Asha, and Will — kids from around the world who have bee...
By PharmaVoice Team • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Relationship Marketing

Relationship marketing has evolved to include the entire spectrum of the healthcare journey. Relationship marketing used to mean developing a relationship between a sales rep and a physician, but today it represents so much more. From fostering relationships between patients, HCPs, industry, and ...
By Robin Robinson • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Are You Ready for Patient Services 2.0?

Today’s patients are far more engaged than the previous era of “doctor knows best." Their voices are amplified through digital, social and popular media, from news programs to Facebook posts, blogs, podcasts, YouTube videos, and documentaries. Powered by the technology they use in their daily liv...
By Bhaskar Sambasivan • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Create Connections. Make a Difference.

Can engagement in online health communities (OHC) improve the quality of life for members while simultaneously having a positive impact on quality of healthcare as a whole? We think so. When it comes to living with a chronic health condition, the challenges can be numerous and disrupt life in man...
By Amrita Bhowmick • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Patient-Centric Approach to Improve the Patient Experience

Access to patients continues to be a key challenge for the industry and with 37% of sites under enrolling and 11% of sites failing to enroll a single patient, things aren’t getting any better. If sponsors and CROs continue to react to challenges as they arise rather than planning for success up f...
By Joyce Moore • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Caring for the Whole Patient

When it comes to supporting patients, the mantra is “put the patient first" or “put the patient at the center of the solution" — rightfully so. Successful marketers will always put the prime audience at the center of all programs, and in order to put the “patient first" or “at the center," it mak...
By Peter Von Bartheld • Oct. 1, 2019
PharmaVoice Team/PharmaVoice

Access Services Programs Affect Product Performance, and Your Brand and Company Reputation

“Repetition penetrates the dullest minds" was a common line I used to hear regularly from a former boss when I was a wet behind the ears product manager. The media’s consistent focus on prescription drug prices and the rising cost of healthcare has penetrated every news channel and stakeholder in...
By Michael Zilligen • Oct. 1, 2019